EP Patent

EP0865789A3 — Pharmaceutical compositions for intranasal administration of dihydroergotamine

Assigned to Individual · Expires 1999-01-07 · 27y expired

What this patent protects

A pharmaceutical composition for nasal administration comprising dihydroergotamine and/or a dihydroergotaminesalt and a cyclodextrin and/or an other saccharide and/or a sugar alcohol.

USPTO Abstract

A pharmaceutical composition for nasal administration comprising dihydroergotamine and/or a dihydroergotaminesalt and a cyclodextrin and/or an other saccharide and/or a sugar alcohol.

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: EP0865789A3
Jurisdiction: EP
Classification: —
Expires: 1999-01-07
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.